ICCC
ImmuCell Corporation
NASDAQ · Healthcare · Biotechnology · US
$9.90
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 117.02x
- PEG TTM
- —
- Price / book
- 2.87x
- Price / sales
- 2.93x
- Price / cash flow
- 15.26x
Enterprise value
- Enterprise value
- $93.5M
- EV / sales
- 3.05x
- EV / EBITDA
- 26.44x
- EV / EBIT
- 24.18x
- Market cap
- $89.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026